This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269–3274.
Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1 H. Blood 2001; 98: 1721–1726.
Keating MJ, Cazin B, Coutre S, Birhiray R, Kovacsovics T, Langer W et al. Campath-1 H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol 2002; 20: 205–213.
Collins RH, Pineiro LA, Agura ED, Fay JW . Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 627–628.
Tanimoto TE, Hirano A, Nagafuji K, Yamasaki S, Hashiguchi M, Okamura T et al. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia. Leukemia 2005; 19: 679–681.
Murase K, Matsunaga T, Sato T, Kuribayashi K, Kogawa K, Kawano Y et al. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. Int J Clin Oncol 2003; 8: 391–394.
Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood 2003; 102: 470–476.
Garderet L, Bittencourt H, Kaliski A, Daniel M, Ribaud P, Socie G et al. Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation. Eur J Haematol 2001; 66: 137–139.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Lavallade, H., Faucher, C., Fürst, S. et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission. Bone Marrow Transplant 37, 709–710 (2006). https://doi.org/10.1038/sj.bmt.1705294
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705294
This article is cited by
-
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
Bone Marrow Transplantation (2017)
-
Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment
Current Oncology Reports (2017)
-
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
Leukemia (2012)
-
Mature T-cell malignancies: a diagnostic and therapeutic challenge
memo - Magazine of European Medical Oncology (2009)
-
Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML
Bone Marrow Transplantation (2008)